Registration - Amendment

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Patient access to medicines in Medicaid including rebate, waiver policy and funding issues. Access to medicines in Medicare; proposed rule on testing of Medicare part B prescription drug models; rebates and Medicare part D - provisions on HHS-OIG Rebate Safe Harbor. Amending protected classes in Medicare. Clarifying or reforming 340B program. Value-based drug contracting. Prescription drug vial sizes. Drug pricing. Co-pay accumulators. Global pharmaceutical supply chain operations and manufacturing locations. Bayh-Dole march-in rights. Medicare Part D Negotiation/Non-Interference Repeal. Medicare Part D Redesign. Notice of Benefit and Payment Parameters. Proposed Medicaid Regulation

LobbyistCovered position, as disclosed
CHRISTOPHER BADGLEY New —
TRICIA BROOKS New —

Medicare/Medicaid MMM

Patient access to medicines in Medicaid including rebate, waiver policy and funding issues. Access to medicines in Medicare; proposed rule on testing of Medicare part B prescription drug models; rebates and Medicare part D - provisions on HHS-OIG Rebate Safe Harbor. Amending protected classes in Medicare. Clarifying or reforming 340B program. Value-based drug contracting. Prescription drug vial sizes. Drug pricing. Co-pay accumulators. Global pharmaceutical supply chain operations and manufacturing locations. Bayh-Dole march-in rights. Medicare Part D Negotiation/Non-Interference Repeal. Medicare Part D Redesign. Notice of Benefit and Payment Parameters. Proposed Medicaid Regulation

LobbyistCovered position, as disclosed
CHRISTOPHER BADGLEY New —
TRICIA BROOKS New —

Medical/Disease Research/Clinical Labs MED

Patient access to medicines in Medicaid including rebate, waiver policy and funding issues. Access to medicines in Medicare; proposed rule on testing of Medicare part B prescription drug models; rebates and Medicare part D - provisions on HHS-OIG Rebate Safe Harbor. Amending protected classes in Medicare. Clarifying or reforming 340B program. Value-based drug contracting. Prescription drug vial sizes. Drug pricing. Co-pay accumulators. Global pharmaceutical supply chain operations and manufacturing locations. Bayh-Dole march-in rights. Medicare Part D Negotiation/Non-Interference Repeal. Medicare Part D Redesign. Notice of Benefit and Payment Parameters. Proposed Medicaid Regulation

LobbyistCovered position, as disclosed
CHRISTOPHER BADGLEY New —
TRICIA BROOKS New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
EISAI CO. LTD. Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.